Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography.
Minordi LM, Scaldaferri F, Larosa L, Marra R, Giordano F, Laterza L, Scoleri I, Poscia A, Gerardi V, Bruno G, Gaetani E, Gasbarrini A, Vecchioli A, Bonomo L. Minordi LM, et al. Among authors: scaldaferri f. Radiol Med. 2015 May;120(5):449-57. doi: 10.1007/s11547-014-0471-3. Epub 2014 Dec 2. Radiol Med. 2015. PMID: 25450867
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome.
Laterza L, Ianiro G, Scoleri I, Landi R, Bruno G, Scaldaferri F, Gaetani E, Campanale M, Gasbarrini A. Laterza L, et al. Among authors: scaldaferri f. Expert Opin Pharmacother. 2015 Mar;16(4):607-15. doi: 10.1517/14656566.2015.1007951. Epub 2015 Feb 1. Expert Opin Pharmacother. 2015. PMID: 25641072 Review.
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.
Scaldaferri F, D'Ambrosio D, Holleran G, Poscia A, Petito V, Lopetuso L, Graziani C, Laterza L, Pistone MT, Pecere S, Currò D, Gaetani E, Armuzzi A, Papa A, Cammarota G, Gasbarrini A. Scaldaferri F, et al. PLoS One. 2017 Oct 26;12(10):e0186575. doi: 10.1371/journal.pone.0186575. eCollection 2017. PLoS One. 2017. PMID: 29073159 Free PMC article.
Risk factors for gastric cancer: is it time to discard PPIs?
Laterza L, Scaldaferri F, Gasbarrini A. Laterza L, et al. Among authors: scaldaferri f. Gut. 2019 Jan;68(1):176-177. doi: 10.1136/gutjnl-2017-315621. Epub 2018 Jan 13. Gut. 2019. PMID: 29331945 No abstract available.
Primary neoplasms of the small bowel at CT: a pictorial essay for the clinician.
Minordi LM, Binda C, Scaldaferri F, Holleran G, Larosa L, Belmonte G, Gasbarrini A, Colosimo C, Manfredi R. Minordi LM, et al. Among authors: scaldaferri f. Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):598-608. doi: 10.26355/eurrev_201802_14281. Eur Rev Med Pharmacol Sci. 2018. PMID: 29461587 Free article. Review.
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease.
Laterza L, Piscaglia AC, Minordi LM, Scoleri I, Larosa L, Poscia A, Ingravalle F, Amato A, Alfieri S, Armuzzi A, Cammarota G, Gasbarrini A, Scaldaferri F. Laterza L, et al. Among authors: scaldaferri f. Dig Dis. 2018;36(3):184-193. doi: 10.1159/000487589. Epub 2018 Mar 7. Dig Dis. 2018. PMID: 29514146
248 results